Pmv Pharmaceuticals, INC Form 4 insider transactions

Director Richard A. Heyman acquired 67,500 stock options in PMV Pharmaceuticals, Inc. on June 6, 2024, according to a Form 4 filing.

Director Carol Gallagher reported the acquisition and subsequent gifting of stock options in PMV Pharmaceuticals.

Director Kirsten Flowers of PMV Pharmaceuticals reports the acquisition of stock options.

Director Charles M. Baum reports the acquisition of stock options in PMV Pharmaceuticals, Inc.